UK markets closed

Reneo Pharmaceuticals, Inc. (RPHM)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.6000-0.2100 (-11.60%)
As of 02:03PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3332
Avg. Estimate-0.44-0.2-0.88-0.53
Low estimate-0.6-0.23-1.01-0.69
High estimate-0.17-0.16-0.82-0.38
Year ago EPS-0.6-0.65-2.52-0.88
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3332
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.6-0.52-0.57-0.58
Actual EPS-0.6-0.65-0.57-0.71
Difference0-0.130-0.13
Surprise %0.00%-25.00%0.00%-22.40%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.44-0.2-0.88-0.53
7 days ago-0.44-0.21-0.91-0.55
30 days ago-0.44-0.21-0.91-0.55
60 days ago-0.29-0.18-0.79-0.56
90 days ago-0.29-0.18-0.84-0.68
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/A111
Up last 30 daysN/A111
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/A111
Growth estimatesRPHMIndustrySector(s)S&P 500
Current qtr.26.70%N/AN/AN/A
Next qtr.69.20%N/AN/AN/A
Current year65.10%N/AN/AN/A
Next year39.80%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A